A Cohort Study on Cardiovascular and Cerebrovascular Outcomes
Plaque-RADS Combined With Vector Flow Imaging in Assessing Carotid Atherosclerotic Risk
1 other identifier
observational
855
1 country
1
Brief Summary
A standardized tool for grading carotid atherosclerotic plaques-dubbed Carotid Plaque-RADS (Reporting and Data System)-has recently been developed. Ultrasound (US) is one of the most frequently utilized methods in carotid screening worldwide. However, the clinical utility of US-based carotid plaque-RADS in refining stroke risk stratification beyond conventional stenosis grading has not been thoroughly validated. This study intends to conduct a bidirectional cohort study. In the retrospective part, we will collect relevant clinical data of patients and combine the Plaque-RADS scoring system to establish a risk regression prediction model for cardiovascular and cerebrovascular events in patients with carotid plaques. We will also prospectively collect a batch of patient data and incorporate ultrasound vector flow imaging and vascular hardness analysis to conduct a prospective cohort study, and further verify the accuracy and effectiveness of the model. Through this research, we aim to identify high-risk patients early, provide early intervention and treatment for high-risk individuals, and reduce the mortality and disability rates of cardiovascular and cerebrovascular diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2021
CompletedFirst Submitted
Initial submission to the registry
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
ExpectedDecember 15, 2025
September 1, 2025
4 years
September 10, 2025
December 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
the occurrence of symptomatic events
12 months after carotid ultrasound examinations
Interventions
Ultrasound (US) is one of the most frequently utilized methods in carotid screening worldwide, because of its noninvasive and radiation-free nature and advantages of cost-effectiveness and convenience。
Eligibility Criteria
patients with asymptomatic carotid plaques who underwent carotid ultrasound examinations.
You may qualify if:
- patients with asymptomatic carotid plaques
You may not qualify if:
- suboptimal image quality or insufficiently detailed examination affecting analysis accuracy;
- recent hemorrhagic cerebral infarction, intracranial hemorrhage, or intracranial neoplasms;
- a prior history of neck radiotherapy or ipsilateral carotid artery surgical/stent procedures;
- lost to follow-up monitoring or had an estimated survival time \<12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 10, 2025
First Posted
September 17, 2025
Study Start
December 30, 2021
Primary Completion
December 30, 2025
Study Completion (Estimated)
December 30, 2027
Last Updated
December 15, 2025
Record last verified: 2025-09